ACCEPTED MANUSCRIPT ] i rises triggered by prolonged exposure to the membrane-permeant oxidizing agent 2,2'-dithiodipyridine were found to be significantly higher in 3xTg-AD neurons when compared to control cultures, suggesting that neuronal expression of pro-AD factors can facilitate altered Zn 2+ homeostasis.
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Alzheimer's disease (AD) is responsible for the most common form of dementia among elderly A C C E P T E D M A N U S C R I P T
INTRODUCTION
Alzheimer's disease (AD) is the most common neurodegenerative disorder of the aging brain.
AD is associated with the appearance of parenchymal deposits of β-amyloid (Aβ) and neurofibrillary tangles made of hyperphosphorylated-tau protein (h-tau) surrounded by altered neuritic processes and reactive glia. Growing evidence suggests that alteration in Zn 2+ levels is an important contributing factor in AD as the cation can induce Aβ oligomerization and plaque formation (Frederickson et al., 2005) .
Zn 2+ is a potent mediator of neuronal death (Sensi and Jeng, 2004) (Aizenman et al., 2000; Bossy-Wetzel et al., 2004; Maret, 2000) . MTs are present in the central nervous system in three isoforms (MT1, 2 and 3), but, while MT1 and MT2 are expressed in astrocytes, MT3 is selectively expressed in neurons (Aschner, 1996) , thereby representing a potential injurious source of releasable Zn 2+ inside of neurons (Lee et al., 2003) . Zn 2+ is sequestered by mitochondria (reviewed in Sensi and Jeng, 2004; Gazaryan et al., 2007; Malaiyandi et al., 2005) and, notably, mitochondrial Zn 2+ can be re-released into the cytosol in a Ca 2+ -dependent fashion (Frazzini et al., 2007; Sensi et al., 2003) . Mitochondrial Zn 2+ accumulation is not always a benign process as the cation can potently disrupt mitochondrial function and
promote strong oxidative stress as well as neuronal death (Brown et al., 2000; Gazaryan et al., 2007; Malaiyandi et al., 2005; Sensi et al., 1999) .
Recent studies suggest ways by which disruption of Zn 2+ homeostasis might play a role in ADrelated neurodegeneration (Frederickson et al., 2005; Religa et al., 2006) . Expression levels of Zn 2+ transporters such as ZnT1, ZnT4 and ZnT6 are altered in the brain of individuals affected by mild cognitive impairment (MCI) and AD (Lovell et al., 2005; Lovell et al., 2006) . Furthermore, studies in AD animal models have shown that genetic ablation of synaptic Zn 2+ (Lee et al., 2002) /Cu 2+ modulator clioquinol has been reported to produce a significant decrease in the rate of cognitive decline in a subset of AD patients (Ritchie et al., 2003) .
Oxidative stress is an additional contributing factor in AD (Butterfield et al., 2001) and in this study, we investigated whether expression of pro-AD factors such as mutant forms of the amyloid precursor protein (APP), presenilin-1 (PS1) and tau protein can modulate ROS-mediated [Zn 2+ ] i rises in cultured cortical neurons obtained from a triple transgenic mouse model of AD (3xTg-AD).
3xTg-AD mice display the major pathological features of the AD brain, including progressive and age-dependent Aβ and tau pathology, and show an early (at 4-6 month of age) intraneuronal accumulation of Aβ in AD-vulnerable hippocampal neurons that well correlates with concomitant appearance of signs of altered synaptic plasticity and cognitive deficits (Billings et al., 2005; Oddo et al., 2003) .
MATERIALS AND METHODS
Materials. FluoZin-3 AM and Newport Green diacetate were purchased from Molecular Probes (Invitrogen, Milan, Italy). 2,2'-dithiodipyridine (DTDP) was purchased from Sigma-Aldrich (Milan, Italy). Tissue culture media and serum were from Gibco (Invitrogen, Milan, Italy). All other chemicals and reagents were obtained from common commercial sources.
Animal cell cultures. All animal procedures were approved by our institutional animal care
and use committee, and are in accordance with the NIH "Principles of laboratory animal care" and national laws. Murine cortical cultures were prepared from embryonic 3xTg-AD, presenilin-1 knock-in (PS1 KI ), and non-Tg (CD1) mice. Neurons were plated upon astrocytic monolayers on poly-lysine + laminin coated coverslips as previously described (Sensi et al., 1999) . 
RESULTS

To evaluate dynamic changes in [Zn
2+
] i levels, cultured (7 D.I.V.) cortical neurons obtained from 3xTg-AD and control mice were loaded with the Zn 2+ -selective fluorescent probes FluoZin-3 or Newport Green (Gee et al., 2002; Sensi et al., 1999) . 3xTg-AD mice have been developed by LaFerla and colleagues by introducing two transgenes (APP swe and tau P301L ) into the germline of the mutant PS1 M146V knock-in mouse (Oddo et al., 2003) , and therefore, in our study, ROS-mediated ] i levels, cytosolic Zn 2+ overload was found to be significantly higher (p< 0.001) in 3xTg-AD cultures (Fig. 2B ).
DISCUSSION
Results presented in this study indicate that expression of pro-AD factors such mutant APP, PS1, and tau can facilitate perturbation of intraneuronal Zn 2+ homeostasis.
DTDP can catalyze disulfide exchange and mobilizes Zn 2+ from MTs in vitro (Jiang et al., 1998) thus, the intraneuronal [Zn 2+ ] i rises observed upon DTDP exposure are likely due to Zn 2+ release from MTs. It should be pointed out that altered Zn 2+ homeostasis, MTs expression, and increased oxidative stress are all playing a critical role in AD and brain aging (Mocchegiani et al., 2005) .
In AD, Aβ generates ROS (Behl et al., 1994) , 2007) . There is compelling evidence that, in the brains of AD subjects and AD animal models, levels of soluble Aβ species correlate better with cognitive decline than plaque density (Gong et al., 2003; Lesne et al., 2006; Lue et al., 1999; Naslund et al., 2000; Oddo et al., 2006a) . Studies in brains from AD patients and AD animal models have shown that formation of Aβ oligomers is initiated intracellularly rather than in the extracellular space (Walsh et al., 2000; Oddo et al., 2006b) and indicated that such process potently impairs synaptic transmission.
In this scenario, altered levels of intraneuronal Zn 2+ might exert a critical role in setting the stage for the formation of an early nidus of intrasynaptic oligomerization of Aβ.
It should be also underlined that brain aging is the major risk factor for AD and is a potently disrupting Zn 2+ homeostasis. Animal studies in neurons from aging hippocampi indicate that MT3 expression is more abundant compared to young hippocampal extracts (Giacconi et al., 2003) . MTs are potent antioxidants and protective factors against stress conditions and increased MT expression in the aging brain may simply reflect a protective endogenous response to a sub-chronic state of inflammatory and/or oxidative stress. On the other hand, it is conceivable that protective actions of MTs can be overridden by a concomitant increase in ROS-driven [Zn 2+ ] i levels. As in the aging brain (and even more so in the AD brain) there is an increase in free radical generation, it is possible that ROS induce a chronic MT up-regulation that leads to higher intracellular availability of A C C E P T E D M A N U S C R I P T 9 releasable Zn 2+ (Mocchegiani et al., 2001; Mocchegiani et al., 2004) . Finally, it should be considered that aging and AD greatly affect mitochondrial capability to cope with both cation loads and oxidative stress and these conditions are associated with increased mutations of mitochondrial DNA as well as expression of defective mitochondrial proteins (Raule et al., 2007; Wallace, 2005) , loads (mean ± SEM) of a 10 min DTDP exposure. * and # indicate differences between 3xTg-AD and PS1 KI or PS1 KI and non-Tg neurons, respectively (p< 0.001).
